Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 713519, 6 pages
http://dx.doi.org/10.1155/2013/713519
Clinical Study

Interferon Alpha Association with Neuromyelitis Optica

1Department of Neurology, Vejle Hospital, 7100 Vejle, Denmark
2Institute of Molecular Medicine, University of Southern Denmark, J.B. Winsloewsvej 19,3, 5000 Odense C, Denmark
3Institute of Regional Health Research, University of Southern Denmark, 29 Sdr. Boulevard, 5000 Odense C, Denmark
4Department of Rheumatology, Odense University Hospital, Winsloewsvej 19B, 2., 5000 Odense C, Denmark
5Department of Biostatistics, University of Southern Denmark, 29 Sdr. Boulevard, 5000 Odense C, Denmark
6Odense Patient Data Explorative Network, Odense University Hospital, Soenderjyllands, Hospital, Egelund 10, 6200 Aabenraa, Denmark
7The Multiple Sclerosis Clinic of Southern Jutland, Vejle, Esbjerg, Soenderborg, Denmark
8Department of Neurology, Sønderborg Hospital, Denmark
9Department of Clinical Immunology, Odense University Hospital, Denmark

Received 21 August 2013; Revised 9 October 2013; Accepted 11 October 2013

Academic Editor: D. Craig Hooper

Copyright © 2013 Nasrin Asgari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [5 citations]

The following is the list of published articles that have cited the current article.

  • Jens Harmel, Marius Ringelstein, Jens Ingwersen, Christian Mathys, Norbert Goebels, Hans-Peter Hartung, Sven Jarius, and Orhan Aktas, “Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab,” BMC Neurology, vol. 14, no. 1, 2014. View at Publisher · View at Google Scholar
  • Reza Khorooshi, Nasrin Asgari, Marlene Thorsen Mørch, Carsten Tue Berg, and Trevor Owens, “Hypersensitivity Responses in the Central Nervous System,” Frontiers in Immunology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Satoru Oji, Eva-Maria Nicolussi, Nathalie Kaufmann, Bleranda Zeka, Kathrin Schanda, Kazuo Fujihara, Zsolt Illes, Charlotte Dahle, Markus Reindl, Hans Lassmann, and Monika Bradl, “Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord,” Plos One, vol. 11, no. 3, 2016. View at Publisher · View at Google Scholar
  • S Miersch, S Kuruganti, M R Walter, and S S Sidhu, “A panel of synthetic antibodies that selectively recognize and antagonize members of the interferon alpha family,” Protein Engineering, Design and Selection, vol. 30, no. 9, pp. 697–704, 2017. View at Publisher · View at Google Scholar
  • Carsten Tue Berg, Reza Khorooshi, Nasrin Asgari, and Trevor Owens, “Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination,” Journal of Neuroinflammation, vol. 14, no. 1, 2017. View at Publisher · View at Google Scholar